Deepa Naishadham
American Cancer Society · 45 works · 26,495 citations · h-index 23
Top works
- Cancer statistics, 2012
- Cancer statistics, 2013
- Predicting US‐ and state‐level cancer counts for the current calendar year
- Predicting US‐ and state‐level cancer counts for the current calendar year
- Experiences of discrimination: Validity and reliability of a self-report measure for population health research on racism and health
- Cancer statistics for Hispanics/Latinos, 2012
- Cancer statistics for African Americans, 2013
- Genetic Variations in Heme Oxygenase-1 and Chronic Hepatitis
- Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C
- Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial
- State Disparities in Colorectal Cancer Mortality Patterns in the United States
- The Influence of Sex, Race/Ethnicity, and Educational Attainment on Human Immunodeficiency Virus Death Rates Among Adults, 1993-2007
- Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
- Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
- Social disparities in the burden of occupational exposures: Results of a cross‐sectional study
- Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C
- Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C
- Age-specific trends in black–white disparities in cervical cancer incidence in the United States: 1975–2009
- Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial†‡
- Iron Levels in Hepatocytes and Portal Tract Cells Predict Progression and Outcomes of Patients With Advanced Chronic Hepatitis C